Ann: Change of Director's Interest Notice - M. Washer, page-24

Interesting question for the Auscann followers: why would they plan to spend millions of dollars on researching and making new "cannabis capsules" when a canopy offshoot (Tweed) already has fully validated final dose forms of softgels (which are easier to administer and have higher absorption) ready to go? Wouldn't it be cheaper, faster to market and way more sensible to just import and sell these?
https://lift.co/oils/tweed-argyle-softgels